Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice

Neurobiology of Aging

Volumn 26, Issue 3, 2005, Pages 309-316

  Wang, Yi Xin ^a  

^a BAYER AG   (Germany)

Author keywords

Angiotensin II; ApoE KO mice; Atherosclerosis; Cardiac hypertrophy; Estrogen; Nitric oxide; Pulse wave velocity; Simvastatin; Vascular stiffening

Indexed keywords

ANGIOTENSIN; APOLIPOPROTEIN E; CELL ADHESION MOLECULE; CHEMOKINE; COLONY STIMULATING FACTOR; ESTRADIOL; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SIMVASTATIN;

ABDOMINAL AORTA ANEURYSM; AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DRUG EFFECT; DRUG RESPONSE; ENDOTHELIUM LESION; GENE ACTIVATION; GLUCOSE BLOOD LEVEL; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; KNOCKOUT MOUSE; LIPID DIET; MITOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CARDIAC OUTPUT, HIGH; CARDIOMEGALY; CARDIOVASCULAR SYSTEM; ENZYME INHIBITORS; ESTRADIOL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; MICE; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; PHENOTYPE; SIMVASTATIN;

EID: 11444265331     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.06.018     Document Type: Conference Paper

References (98)

1. T.J. Anderson, M.D. Gerhard, I.T. Meredith, F. Charbonneau, D. Delagrange, and M.A. Creager Systemic nature of endothelial dysfunction in atherosclerosis Am J Cardiol 75 6 1995 B71 B74
2. R. Asmar, A. Benetos, J. Topouchian, P. Laurent, B. Pannier, and A.M. Brisac Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies Hypertension 26 3 1995 485 490
3. J. Atkinson, P. Poitevin, J.M. Chillon, I. Lartaud, and B. Levy Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats Am J Physiol 266 2 Pt 2 1994 H540 H547
4. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Annu Rev Immunol 12 1994 141 179
5. K.R. Bales, T. Verina, R.C. Dodel, Y. Du, L. Altstiel, and M. Bender Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat Genet 17 3 1997 263 264
6. S. Bertolini, G.B. Bon, L.M. Campbell, M. Farnier, J. Langan, and G. Mahla Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia Atherosclerosis 130 1/2 1997 191 197
7. N.H. Bjarnason, J. Haarbo, I. Byrjalsen, P. Alexandersen, R.F. Kauffman, and C. Christiansen Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits Atherosclerosis 154 1 2001 97 102
8. L. Bocksch, T. Stephens, A. Lucas, and B. Singh Apolipoprotein E: possible therapeutic target for atherosclerosis Curr Drug Targets Cardiovasc Haematol Disord 1 2 2001 93 106
9. D. Bouthillier, C.F. Sing, and J. Davignon Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings J Lipid Res 24 8 1983 1060 1069
10. A.R. Brasier, M. Jamaluddin, Y. Han, C. Patterson, and M.S. Runge Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor Mol Cell Biochem 212 1/2 2000 155 169
11. P.M. Bretsky, J.G. Buckwalter, T.E. Seeman, C.A. Miller, J. Poirier, and G.D. Schellenberg Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease Alzheimer Dis Assoc Disord 13 4 1999 216 221
12. R. Busse, I. Fleming, and V.B. Schini Nitric oxide formation in the vascular wall: regulation and functional implications Curr Top Microbiol Immunol 196 1995 7 18
13. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 1993 921 923
14. A. Dart, G. Jerums, G. Nicholson, M. d'Emden, I. Hamilton-Craig, and G. Tallis A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia [see comments] Am J Cardiol 80 1 1997 39 44
15. A. Daugherty, and L. Cassis Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice Ann NY Acad Sci 892 1999 108 118
16. A. Daugherty, M.W. Manning, and L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice J Clin Invest 105 11 2000 1605 1612
17. R. De Caterina, P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, and M.A. Gimbrone Jr. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines J Clin Invest 96 1 1995 60 68
18. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J Biol Chem 274 45 1999 32048 32054
19. G.G. Deng, B. Martin-McNulty, D.A. Sukovich, A. Freay, M. Halks-Miller, and T. Thinnes Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm Circ Res 92 5 2003 510 517
20. P. Dimayuga, J. Zhu, S. Oguchi, K.Y. Chyu, X.O. Xu, and J. Yano Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice Biochem Biophys Res Commun 264 2 1999 465 468
21. K. Egashira, Q. Zhao, C. Kataoka, K. Ohtani, M. Usui, and I.F. Charo Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys Circ Res 90 11 2002 1167 1172
22. M.J. Evans, A. Eckert, K. Lai, S.J. Adelman, and D.C. Harnish Reciprocal antagonism between estrogen receptor and NF-{kappa}B activity in vivo Circ Res 89 9 2001 823 830
23. D.J. Farrar, M.G. Bond, W.A. Riley, and J.K. Sawyer Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys Circulation 83 5 1991 1754 1763
24. D.J. Farrar, M.G. Bond, J.K. Sawyer, and H.D. Green Pulse wave velocity and morphological changes associated with early atherosclerosis progression in the aortas of cynomolgus monkeys Cardiovasc Res 18 2 1984 107 118
25. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, and P. Keller Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo Proc Natl Aacd Sci 98 10 2001 5856 5861
26. R. Fitch, V. Da Cunha, K. Kauser, W. Dole, J. Parkinson, and R. Vergona Increased nitric oxide accounts for decreased basal vascular tone and responsiveness in the resistance vessels of high-cholesterol-fed rabbits Pharmacology 63 4 2001 220 227
27. R.M. Fitch, R. Vergona, M.E. Sullivan, and Y.-X. Wang Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats Cardiovasc Res 51 2 2001 351 358
28. Y. Furukawa, A. Matsumori, N. Ohashi, T. Shioi, K. Ono, and A. Harada Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries Circ Res 84 3 1999 306 314
29. L. Guo, M.J. LaDu, and L.J. Van Eldik A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity J Mol Neurosci 23 3 2004 205 212
30. C.J. Hartley, A.K. Reddy, S. Madala, B. Martin-McNulty, R. Vergona, and M.E. Sullivan Hemodynamic changes in apolipoprotein E-knockout mice Am J Physiol Heart Circ Physiol 279 5 2000 H2326 H2334
31. C.J. Hartley, G.E. Taffet, L.H. Michael, T.T. Pham, and M.L. Entman Noninvasive determination of pulse-wave velocity in mice Am J Physiol 273 1 Pt 2 1997 H494 H500
32. G.S. Herron, E. Unemori, M. Wong, J.H. Rapp, M.H. Hibbs, and R.J. Stoney Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms Arterioscler Thromb 11 6 1991 1667 1677
33. T. Hirai, S. Sasayama, T. Kawasaki, and S. Yagi Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis [published erratum appears in Circulation 1989 Dec;80(6):1946] Circulation 80 1 1989 78 86
34. J.B. Hodgin, J.H. Krege, R.L. Reddick, K.S. Korach, O. Smithies, and N. Maeda Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in ApoE-/- mice J Clin Invest 107 3 2001 333 340
35. A. Hofman, A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, and F. van Harskamp Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 9046 1997 151 154
36. C. Horvath, F.G. Welt, M. Nedelman, P. Rao, and C. Rogers Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted Circ Res 90 4 2002 488 494
37. C.L. Hunter, H.A. Bimonte-Nelson, M. Nelson, C.B. Eckman, and A.C. Granholm Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen Neurobiol Aging 25 7 2004 873 884
38. C. Iadecola Atherosclerosis and neurodegeneration: unexpected conspirators in Alzheimer's dementia Arterioscler Thromb Vasc Biol 23 11 2003 1951 1953
39. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 9242 2000 1627 1631
40. P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) [published erratum appears in Am J Cardiol 1998 Jul 1;82(1):128; see comments] Am J Cardiol 81 5 1998 582 587
41. K. Kauser, V. da Cunha, R. Fitch, C. Mallari, and G.M. Rubanyi Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol 278 5 2000 H1679 H1685
42. H. Kazama, N.N. Ruberu, S. Murayama, Y. Saito, K.I. Nakahara, and K. Kanemaru Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles Dement Geriatr Cogn Disord 18 2 2004 145 150
43. T. Kocjan, and G.M. Prelevic Hormone replacement therapy update: who should we be prescribing this to now? Curr Opin Obstet Gynecol 15 6 2003 459 464
44. A. Kumar, J.L. Hoover, C.A. Simmons, V. Lindner, and R.J. Shebuski Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice Circulation 96 12 1997 4333 4342
45. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 12 1998 1129 1135
46. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 37 1998 24266 24271
47. E.D. Lehmann Pulse wave velocity as a marker of vascular disease - reply Lancet 348 1996 1587
48. E.D. Lehmann, K.D. Hopkins, R.L. Jones, A.G. Rudd, and R.G. Gosling Aortic distensibility in patients with cerebrovascular disease Clin Sci (Colch) 89 3 1995 247 253
49. S. Lookinland, and R.L. Beckstrand HRT: decide based on the evidence Nurse Pract 28 9 2003 46 54
50. R.W. Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Annu Rev Genomics Hum Genet 1 2000 507 537
51. J. Maldonado, E. Galhano, L. Almeida, M. Pego, M. Bastos, and S. Cabrita Pulse wave velocity as initial marker of atherosclerosis Rev Port Cardiol 13 11 1994 845 851 08
52. B. Martin-McNulty, D.M. Tham, V. Da Cunha, J.J. Ho, D.W. Wilson, and J.C. Rutledge 17{beta}-Estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 9 2003 1627 1632
53. N. Marx, G.K. Sukhova, T. Collins, P. Libby, and J. Plutzky PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 99 24 1999 3125 3131
54. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 23 1999 1801 1811
55. L. Nathan, S. Pervin, R. Singh, M. Rosenfeld, and G. Chaudhuri Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis Circ Res 85 4 1999 377 385
56. W. Nichols, and O'rourke MF McDonald's blood flow in arteries. Theoretical experimental and clinical principles 1998 Arnold London
57. J. Niebauer, A.J. Maxwell, P.S. Lin, P.S. Tsao, J. Kosek, and D. Bernstein Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training Am J Physiol 276 4 Pt 2 1999 H1346 H1354
58. S. Oguchi, P. Dimayuga, J. Zhu, K.Y. Chyu, J. Yano, and P.K. Shah Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice Arterioscler Thromb Vasc Biol 20 7 2000 1729 1736
59. H.B. Peng, P. Libby, and J.K. Liao Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B J Biol Chem 270 23 1995 14214 14219
60. S. Pervin, R. Singh, M.E. Rosenfeld, M. Navab, G. Chaudhuri, and L. Nathan Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis Arterioscler Thromb Vasc Biol 18 10 1998 1575 1582
61. J.A. Piedrahita, S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells Proc Natl Acad Sci USA 89 10 1992 4471 4475
62. A.S. Plump, J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, and J.G. Verstuyft Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 71 2 1992 343 353
63. J. Poirier Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism Ann NY Acad Sci 924 2000 81 90
64. J. Poirier Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease Mol Diagn 4 4 1999 335 341
65. C. Rogers, E.R. Edelman, and D.I. Simon A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits Proc Natl Acad Sci USA 95 17 1998 10134 10139
66. A.E. Roher, C. Esh, T.A. Kokjohn, W. Kalback, D.C. Luehrs, and J.D. Seward Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease Arterioscler Thromb Vasc Biol 23 11 2003 2055 2062
67. M.E. Rosenfeld, K. Kauser, B. Martin-McNulty, P. Polinsky, S.M. Schwartz, and G.M. Rubanyi Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice Atherosclerosis 164 2 2002 251 259
68. M.E. Rosenfeld, P. Polinsky, R. Virmani, K. Kauser, G. Rubanyi, and S.M. Schwartz Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse Arterioscler Thromb Vasc Biol 20 12 2000 2587 2592
69. R. Ross Atherosclerosis is an inflammatory disease Am Heart J 138 5 Pt 2 1999 S419 S420
70. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, and M. Karin Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase Nature 403 6765 2000 103 108
71. G.M. Rubanyi, and P.M. Vanhoutte Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle Am J Physiol 250 5 Pt 2 1986 815 821
72. M. Sato, Y. Katsuki, H. Kanehiro, M. Iimura, Y. Akada, and M. Mizota Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits J Cardiovasc Pharmacol 22 1 1993 1 9
73. A.M. Saunders, M.K. Trowers, R.A. Shimkets, S. Blakemore, D.J. Crowther, and T.A. Mansfield The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection Biochim Biophys Acta 1502 1 2000 85 94
74. J. Schneiderman, G.M. Bordin, R. Adar, A. Smolinsky, D. Seiffert, and I. Engelberg Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms Am J Pathol 152 3 1998 703 710
75. J. Schneiderman, G.M. Bordin, I. Engelberg, R. Adar, D. Seiffert, and T. Thinnes Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion J Clin Invest 96 1 1995 639 645
76. S.A. Schreyer, C. Vick, T.C. Lystig, P. Mystkowski, and R.C. LeBoeuf LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice Am J Physiol Endocrinol Metab 282 1 2002 E207 E214
77. M.P. Senaratne, A.B. Thomson, and C.T. Kappagoda Lovastatin prevents the impairment of endothelium dependent relaxation and inhibits accumulation of cholesterol in the aorta in experimental atherosclerosis in rabbits Cardiovasc Res 25 7 1991 568 578
78. P.K. Shah Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken Circulation 107 17 2003 2175 2177
79. P.K. Shireman, W.J. McCarthy, W.H. Pearce, V.P. Shively, M. Cipollone, and H.C. Kwaan Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta J Vasc Surg 25 1 1997 157 164
80. D.I. Simon, Z. Dhen, P. Seifert, E.R. Edelman, C.M. Ballantyne, and C. Rogers Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty J Clin Invest 105 3 2000 293 300
81. C.A. Smith, C.A. McCleary, G.A. Murdock, T.W. Wilshire, D.K. Buckwalter, and P. Bretsky Lifelong estrogen exposure and cognitive performance in elderly women Brain Cogn 39 3 1999 203 218
82. J.D. Smith, H.M. Dansky, and J.L. Breslow Genetic modifiers of atherosclerosis in mice Ann NY Acad Sci 947 2001 247 252 [discussion 52-3]
83. D.L. Sparks, S.W. Scheff, J.C. Hunsaker III, H. Liu, T. Landers, and D.R. Gross Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol Exp Neurol 126 1 1994 88 94
84. D.A. Sukovich, K. Kauser, F.D. Shirley, V. DelVecchio, M. Halks-Miller, and G.M. Rubanyi Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol Arterioscler Thromb Vasc Biol 18 9 1998 1498 1505
85. D.M. Tham, B. Martin-McNulty, Y.-X. Wang, V. Da Cunha, D.W. Wilson, and C.N. Athanassious Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice Am J Physiol Regul Integr Comp Physiol 283 6 2002 R1442 R1449
86. D.M. Tham, B. Martin-McNulty, Y.-X. Wang, D.W. Wilson, R. Vergona, and M.E. Sullivan Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs Physiol Genom 11 1 2002 21 30
87. D.M. Tham, Y.-X. Wang, and J.C. Rutledge Modulation of vascular inflammation by PPARs Drug News Perspect 16 2 2003 109 116
88. C.B. Treasure, J.L. Klein, W.S. Weintraub, J.D. Talley, M.E. Stillabower, and A.S. Kosinski Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 8 1995 481 487
89. J. Tse, B. Martin-McNaulty, M. Halks-Miller, K. Kauser, V. DelVecchio, and R. Vergona Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol Atherosclerosis 144 2 1999 303 313
90. M. Usui, K. Egashira, K. Ohtani, C. Kataoka, M. Ishibashi, and K. Hiasa Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys FASEB J 16 13 2002 1838 1840 [Epub 2002 September 5]
91. Y.-X. Wang, R. Fitch, W. Li, M. Werner, M. Halks-Miller, and B. Lillis Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis Vascul Pharmacol 39 1/2 2002 69 76
92. Y.-X. Wang, M. Halks-Miller, R. Vergona, M.E. Sullivan, R. Fitch, and C. Mallari Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol 278 2 2000 H428 H434
93. Y.-X. Wang, B. Martin-McNulty, A.D. Freay, D.A. Sukovich, M. Halks-Miller, and W.W. Li Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice Am J Pathol 159 4 2001 1455 1464
94. Y.-X. Wang, B. Martin-McNulty, L.Y. Huw, V. da Cunha, J. Post, and J. Hinchman Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E Atherosclerosis 162 1 2002 23 31
95. D. Weiss, D. Sorescu, and W.R. Taylor Angiotensin II and atherosclerosis Am J Cardiol 87 8A 2001 25C 32C
96. F.K. Welty Alternative hormone replacement regimens: is there a need for further clinical trials? Curr Opin Lipidol 14 6 2003 585 591
97. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch Neurol 57 10 2000 1439 1443
98. Z. Zhou, M.S. Penn, F. Forudi, X. Zhou, K. Tarakji, and E.J. Topol Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model Arterioscler Thromb Vasc Biol 22 10 2002 1598 1603